These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3136426)

  • 1. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
    Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary Corynebacterium group D2 infections. A hospital epidemic and antibiotic sensitivity].
    Fosse T; Carles D; Laffont C; Lefebvre JC; Bocquet JP
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):742-5. PubMed ID: 3054760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of norfloxacin with aminoglycosides, tetracycline and chloramphenicol.
    Mascellino MT; Lorenzi A; Bonanni M; Iegri F
    Drugs Exp Clin Res; 1986; 12(4):319-23. PubMed ID: 3720519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H
    Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium pseudogenitalium urinary tract infection.
    Vedel G; Toussaint G; Riegel P; Fouilladieu JL; Billöet A; Poyart C
    Emerg Infect Dis; 2006 Feb; 12(2):355-6. PubMed ID: 17080582
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.
    Soriano F; Ponte C; Santamaría M; Torres A; Fernández-Roblas R
    J Antimicrob Chemother; 1987 Sep; 20(3):349-55. PubMed ID: 3479417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of coryneform bacteria from blood cultures of patients at a University Hospital in Saudi Arabia.
    Babay HA; Kambal AM
    Saudi Med J; 2004 Aug; 25(8):1073-9. PubMed ID: 15322601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections caused by antibiotic-resistant Corynebacterium group D2.
    Soriano F; Fernández-Roblas R
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):337-41. PubMed ID: 3137032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
    Chudnicka A; Kozioł-Montewka M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic-resistant Corynebacteria--a new problem of infection in immunosuppressed patients].
    Osterwalder B; Frei R; Gratwohl A; Reber H; Speck B
    Schweiz Med Wochenschr; 1986 Jun; 116(26):880-4. PubMed ID: 3738458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity curves of multiply resistant corynebacteria JK and D2].
    Rauturier M; Darbas H; Jean-Pierre H; Boyer G; Rivière M
    Pathol Biol (Paris); 1990 May; 38(5):420-5. PubMed ID: 2142275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incrusted cystitis with isolation of Corynebacterium group D2].
    Fernández Natal MI; García Díez F; Salas Valién JS; Cachón García F; Soriano García F
    Med Clin (Barc); 1992 Mar; 98(11):419-22. PubMed ID: 1533260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.